Heart Neoplasm
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Polyhydramnios
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Nausea and vomiting
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Congenital malrotation of intestine
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Decreased peristalsis
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Sepsis
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Microcolon
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Dilatation of ureter
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Congenital omphalocele
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Congenital exomphalos
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Megacystis
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Death in infancy
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Multicystic Dysplastic Kidney
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Intracranial Aneurysm
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Among all DEGs, 5 down-regulated genes (MYH11, CNN1, MYOCD, ACTA1, and LMOD1) and 3 up-regulated genes (C1QB, C3AR1, and VSIG4) are most relevant in IA formation.
|
31238169 |
2019 |
Colorectal Carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Genes such as ACTA2, ACTG2, MYH11, CALD1, MYL9, TPM2, and LMOD1 were strongly implicated in CRC.
|
30786729 |
2019 |
Squamous cell carcinoma of esophagus
|
0.010 |
Biomarker
|
disease |
BEFREE |
By bioinformatics analysis, the four up-regulated proteins (PTMA, PAK2, PPP1CA, HMGB2) and the five down-regulated proteins (Caveolin, Integrin beta-1, Collagen alpha-2(VI), Leiomodin-1 and Vinculin) were selected and validated in ESCC by Western Blot.
|
30988666 |
2019 |
Coronary heart disease
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Functional regulatory mechanism of smooth muscle cell-restricted LMOD1 coronary artery disease locus.
|
30444878 |
2018 |
Trichohepatoenteric Syndrome
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
The molecular basis of this condition started to be defined recently, and the genes related to the syndrome (ACTG2-heterozygous variant in sporadic cases; and MYH11 (myosin heavy chain 11), LMOD1 (leiomodin 1) and MYLK (myosin light chain (MLC) kinase)-autosomal recessive inheritance), encode proteins involved in the smooth muscle contraction, supporting a myopathic basis for the disease.
|
29453416 |
2018 |
SMITH-MCCORT DYSPLASIA 1
|
0.010 |
Biomarker
|
disease |
BEFREE |
LMOD1 knockdown results in increased proliferation and migration and decreased cell contraction in HCASMC, and immunostaining in atherosclerotic lesions in the SMC lineage tracing reporter mouse support a key role for LMOD1 in maintaining the differentiated SMC phenotype.
|
30444878 |
2018 |
Arteriosclerosis
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
We identified 25 new SNP-CAD associations (P < 5 × 10<sup>-8</sup>, in fixed-effects meta-analysis) from 15 genomic regions, including SNPs in or near genes involved in cellular adhesion, leukocyte migration and atherosclerosis (PECAM1, rs1867624), coagulation and inflammation (PROCR, rs867186 (p.Ser219Gly)) and vascular smooth muscle cell differentiation (LMOD1, rs2820315).
|
28530674 |
2017 |
Atherosclerosis
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
We identified 25 new SNP-CAD associations (P < 5 × 10<sup>-8</sup>, in fixed-effects meta-analysis) from 15 genomic regions, including SNPs in or near genes involved in cellular adhesion, leukocyte migration and atherosclerosis (PECAM1, rs1867624), coagulation and inflammation (PROCR, rs867186 (p.Ser219Gly)) and vascular smooth muscle cell differentiation (LMOD1, rs2820315).
|
28530674 |
2017 |
Nodding Syndrome
|
0.010 |
Biomarker
|
disease |
BEFREE |
Antibodies targeting leiomodin-1 were neurotoxic in vitro, and leiomodin-1 antibodies purified from patients with nodding syndrome were cross-reactive with <i>O. volvulus</i> antigens.
|
28202777 |
2017 |
leiomyosarcoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
We identified two new formalin-fixed, paraffin-embedded tissue-compatible diagnostic immunohistochemical markers; LMOD1 for subtype I leiomyosarcoma and ARL4C for subtype II leiomyosarcoma.
|
25896974 |
2015 |
Adult Leiomyosarcoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
We identified two new formalin-fixed, paraffin-embedded tissue-compatible diagnostic immunohistochemical markers; LMOD1 for subtype I leiomyosarcoma and ARL4C for subtype II leiomyosarcoma.
|
25896974 |
2015 |
Childhood Leiomyosarcoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
We identified two new formalin-fixed, paraffin-embedded tissue-compatible diagnostic immunohistochemical markers; LMOD1 for subtype I leiomyosarcoma and ARL4C for subtype II leiomyosarcoma.
|
25896974 |
2015 |